PERMEON BIOLOGICS, INC.

Profile

Company Names

PERMEON BIOLOGICS, INC.
NEWCO LS15, INC.

Addresses

ONE KENDALL SQUARE, BLDG 1400W, 3RD FL, STE. 1, CAMBRIDGE, MA 02139

ONE MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-945-7780
617-218-1567

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$6,000,600.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-12-19 
$2,500,600.00 
$2,500,600.00 
$0.00 
Equity, Debt 
1
2010-11-23 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NOUBAR 
 
AFEYAN, PH.D. 
DIRECTOR
NEWCO LS15, INC.   |  PERMEON BIOLOGICS, INC.
DOUGLAS 
 
COLE, M.D. 
DIRECTOR
NEWCO LS15, INC.
DOUGLAS 
G. 
COLE, M.D. 
DIRECTOR
PERMEON BIOLOGICS, INC.
KEITH 
L. 
CRANDELL 
DIRECTOR
QUANTERIX CORP   |  NEWCO LS15, INC.   |  PERMEON BIOLOGICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  CYTRELLIS BIOSYSTEMS, INC.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
JOHN 
 
EDWARDS 
EXECUTIVE OFFICER, DIRECTOR
MOVE NETWORKS INC   |  PERMEON BIOLOGICS, INC.   |  MACULOGIX, INC.   |  AVAXIA BIOLOGICS, INC   |  IMMUNEXCITE, INC.   |  RENOVA PCA, LLC   |  TILOS THERAPEUTICS, INC.   |  ABCURO, INC.   |  PANTHER THERAPEUTICS, INC.
ALEX 
 
FRANZUSOFF 
EXECUTIVE OFFICER
NEWCO LS15, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-12-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-12-19 
2010-12-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#